BRIDGER MANAGEMENT, LLC - Q1 2015 holdings

$1.5 Billion is the total value of BRIDGER MANAGEMENT, LLC's 38 reported holdings in Q1 2015. The portfolio turnover from Q4 2014 to Q1 2015 was 33.3% .

 Value Shares↓ Weighting
LH BuyLABORATORY CORP AMER HLDGS$80,625,000
+54.7%
639,422
+32.4%
5.39%
+64.2%
ZTS BuyZOETIS INCcl a$78,472,000
+64.0%
1,695,228
+52.5%
5.24%
+74.1%
AGO BuyASSURED GUARANTY LTD$69,625,000
+14.0%
2,638,300
+12.3%
4.65%
+21.0%
CAH BuyCARDINAL HEALTH INC$67,305,000
+35.8%
745,592
+21.4%
4.50%
+44.2%
UNH BuyUNITEDHEALTH GROUP INC$67,142,000
+28.7%
567,605
+9.9%
4.49%
+36.6%
ALNY BuyALNYLAM PHARMACEUTICALS INC$65,446,000
+19.5%
626,758
+11.0%
4.38%
+26.9%
MPC NewMARATHON PETE CORP$58,502,000571,362
+100.0%
3.91%
MNKKQ NewMALLINCKRODT PUB LTD CO$57,677,000455,405
+100.0%
3.86%
POST BuyPOST HLDGS INC$53,881,000
+32.5%
1,150,316
+18.5%
3.60%
+40.7%
HUM BuyHUMANA INC$53,624,000
+113.5%
301,224
+72.2%
3.58%
+126.7%
CNC BuyCENTENE CORP DEL$37,337,000
+38.9%
528,176
+104.0%
2.50%
+47.4%
ARAY BuyACCURAY INC$36,299,000
+26.9%
3,903,090
+3.1%
2.43%
+34.8%
PFSI BuyPENNYMAC FINL SVCS INCcl a$34,364,000
+3.2%
2,025,000
+5.2%
2.30%
+9.5%
TGTX BuyTG THERAPEUTICS INC$31,762,000
+12.6%
2,051,821
+15.2%
2.12%
+19.5%
LLY NewLILLY ELI & CO$26,655,000366,893
+100.0%
1.78%
THC BuyTENET HEALTHCARE CORP$26,096,000
+1.1%
527,088
+3.5%
1.74%
+7.3%
KYTH NewKYTHERA BIOPHARMACEUTICALS I$22,317,000444,999
+100.0%
1.49%
ARWR BuyARROWHEAD RESH CORP$20,134,000
+15.9%
2,976,183
+26.4%
1.35%
+23.0%
ATRA BuyATARA BIOTHERAPEUTICS INC$19,739,000
+203.1%
474,835
+95.0%
1.32%
+221.7%
TROV BuyTROVAGENE INC$19,412,000
+110.7%
2,850,587
+33.0%
1.30%
+123.8%
CMRX BuyCHIMERIX INC$17,837,000
+12.0%
473,256
+19.6%
1.19%
+18.8%
IRWD NewIRONWOOD PHARMACEUTICALS INC$13,448,000840,479
+100.0%
0.90%
CCJ BuyCAMECO CORP$11,333,000
+188.6%
813,586
+240.0%
0.76%
+206.9%
AMRI NewALBANY MOLECULAR RESH INC$7,041,000400,056
+100.0%
0.47%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2015-05-15
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
VERISIGN INC40Q1 20235.2%
TEVA PHARMACEUTICAL INDS LTD40Q3 20237.3%
MORGAN STANLEY35Q3 202311.8%
ALNYLAM PHARMACEUTICALS INC34Q3 20214.9%
POST HLDGS INC33Q4 20226.1%
TG THERAPEUTICS INC33Q3 20213.8%
CHARTER COMMUNICATIONS INC N30Q3 20237.2%
ATARA BIOTHERAPEUTICS INC29Q4 20216.4%
GODADDY INC28Q3 20238.9%
CENTENE CORP DEL28Q3 20226.2%

View BRIDGER MANAGEMENT, LLC's complete holdings history.

Latest significant ownerships (13-D/G)
BRIDGER MANAGEMENT, LLC Q1 2015 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
Surrozen, Inc./DESold outFebruary 14, 202200.0%
Atara Biotherapeutics, Inc.February 16, 20211,524,7601.8%
Dicerna Pharmaceuticals IncFebruary 14, 20201,981,6332.9%
TG THERAPEUTICS, INC.February 14, 20201,907,4921.9%
CHIMERIX INCSold outFebruary 14, 201700.0%
PACIFIC BIOSCIENCES OF CALIFORNIA, INC.Sold outFebruary 14, 201700.0%
SeaSpine Holdings CorpSold outFebruary 14, 201700.0%
Trovagene, Inc.Sold outFebruary 14, 201700.0%
ARROWHEAD RESEARCH CORPSold outFebruary 16, 201600.0%
PENNYMAC FINANCIAL SERVICES, INC.Sold outFebruary 16, 201600.0%

View BRIDGER MANAGEMENT, LLC's complete significant-ownership history.

Latest filings
TypeFiled
13F-HR/A2024-03-25
13F-HR/A2024-03-25
13F-HR/A2024-03-25
13F-HR/A2024-03-25
13F-HR/A2024-03-25
13F-HR/A2024-03-25
13F-HR/A2024-03-25
13F-HR2024-02-14
13F-HR2023-11-14
13F-HR2023-08-14

View BRIDGER MANAGEMENT, LLC's complete filings history.

Compare quarters

Issues

The following issues were detected while analyzing the report:

  • The reported total value is incorrect (1496074000.0 != 1496077000.0)

Export BRIDGER MANAGEMENT, LLC's holdings